Colorectal adenoma
Conditions
Interventions
Group A:After the operation, Kangfuxin solution (10ml/ time, three times a day, oral) was routinely taken for 7 days. If the patient can not tolerate it, then stop the Kangfuxin solution.
Group B:No Kangfuxin solution was taken after surgery.
Sponsors
Shenzhen People's Hospital (the Second Clinical Medical College of Jinan University, the First Affiliated Hospital of South University of science and Technology)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ?Patients aged 18-80 years, male and female;?patients with colorectal adenoma (10mm=d=20mm) and received EMR treatment;?patients who sign the written informed consent;?the specimen was confirmed with adenomatous polyp by pathology.
Exclusion criteria
Exclusion criteria: ?Patients with abnormal colorectal anatomy and could not complete endoscopic surgery;?patient with colorectal adenoma with diameter less than 10mm or larger than 20mm;?pregant women;?severe heart, liver, and kidney dysfunction;?patients with coagulation dysfunction;?other identifiable causes of infection, fever, and elevated WBC, such as pneumonia;?allergic to drug ingredients;?patients with inflammatory bowel disease, Crohn's disease, familial polyps, and those who were not considered suitable for participants by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bleeding;perforation;abdominal pain;fever;elevated white blood cells; | — |
Secondary
| Measure | Time frame |
|---|---|
| procedure duration; | — |
Countries
China
Contacts
Public ContactJun Yao
Shenzhen People's Hospital (the Second Clinical Medical College of Jinan University, the First Affiliated Hospital of South University of science and Technology)
Outcome results
None listed